WallStSmart

Triple Flag Precious Metals Corp (TFPM)vsVersamet Royalties Corporation Common Stock (VMET)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Triple Flag Precious Metals Corp generates 720% more annual revenue ($453.45M vs $55.27M). TFPM leads profitability with a 68.7% profit margin vs 58.4%. TFPM trades at a lower P/E of 18.7x. TFPM earns a higher WallStSmart Score of 70/100 (B-).

TFPM

Strong Buy

70

out of 100

Grade: B-

Growth: 10.0Profit: 8.5Value: 5.3Quality: 9.0
Piotroski: 4/9Altman Z: 18.77

VMET

Buy

58

out of 100

Grade: C

Growth: 10.0Profit: 8.5Value: 4.7Quality: 7.5
Piotroski: 5/9Altman Z: 1.19

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

TFPM6 strengths · Avg: 10.0/10
Profit MarginProfitability
68.7%10/10

Keeps 69 of every $100 in revenue as profit

Operating MarginProfitability
66.9%10/10

Strong operational efficiency at 66.9%

Revenue GrowthGrowth
78.7%10/10

Revenue surging 78.7% year-over-year

EPS GrowthGrowth
147.2%10/10

Earnings expanding 147.2% YoY

Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
18.7710/10

Safe zone — low bankruptcy risk

VMET5 strengths · Avg: 9.8/10
Profit MarginProfitability
58.4%10/10

Keeps 58 of every $100 in revenue as profit

Operating MarginProfitability
90.6%10/10

Strong operational efficiency at 90.6%

Revenue GrowthGrowth
594.0%10/10

Revenue surging 594.0% year-over-year

EPS GrowthGrowth
573.0%10/10

Earnings expanding 573.0% YoY

Debt/EquityHealth
0.129/10

Conservative balance sheet, low leverage

Areas to Watch

TFPM0 concerns · Avg: 0/10

No major concerns identified

VMET3 concerns · Avg: 3.0/10
P/E RatioValuation
37.5x4/10

Premium valuation, high expectations priced in

Market CapQuality
$1.26B3/10

Smaller company, higher risk/reward

Altman Z-ScoreHealth
1.192/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : TFPM

The strongest argument for TFPM centers on Profit Margin, Operating Margin, Revenue Growth. Profitability is solid with margins at 68.7% and operating margin at 66.9%. Revenue growth of 78.7% demonstrates continued momentum.

Bull Case : VMET

The strongest argument for VMET centers on Profit Margin, Operating Margin, Revenue Growth. Profitability is solid with margins at 58.4% and operating margin at 90.6%. Revenue growth of 594.0% demonstrates continued momentum.

Bear Case : TFPM

No major red flags identified for TFPM, but monitor valuation.

Bear Case : VMET

The primary concerns for VMET are P/E Ratio, Market Cap, Altman Z-Score.

Key Dynamics to Monitor

VMET is growing revenue faster at 594.0% — sustainability is the question.

TFPM generates stronger free cash flow (82M), providing more financial flexibility.

Monitor OTHER PRECIOUS METALS & MINING industry trends, competitive dynamics, and regulatory changes.

Bottom Line

TFPM scores higher overall (70/100 vs 58/100), backed by strong 68.7% margins and 78.7% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Triple Flag Precious Metals Corp

BASIC MATERIALS · OTHER PRECIOUS METALS & MINING · USA

Triple Flag Precious Metals Corp (TFPM) is a prominent precious metals streaming and royalty company, adeptly providing innovative capital solutions to the mining industry by securing a share of future production. With a well-diversified portfolio located in premier mining jurisdictions, TFPM effectively mitigates operational risks while leveraging the increasing global demand for gold and silver. The company's distinct financial model enhances mining operations and positions it to benefit from favorable market trends in precious metals. Supported by a strong management team and a solid balance sheet, Triple Flag is strategically positioned to capitalize on sustainable mining opportunities, presenting itself as an appealing investment option for institutional investors focused on resilience and growth in their commodity allocations.

Visit Website →

Versamet Royalties Corporation Common Stock

BASIC MATERIALS · OTHER PRECIOUS METALS & MINING · USA

Viamet Pharmaceuticals Corp (VMET) is a biopharmaceutical company focused on developing cutting-edge therapeutics for serious diseases, leveraging its proprietary metalloenzyme-based technology platform. The company is committed to addressing significant unmet medical needs in fungal infections and oncology, positioning itself as a leader in therapeutic innovation. With a diverse pipeline bolstered by strategic collaborations and a strong intellectual property portfolio, Viamet is well-prepared to advance its clinical initiatives and enhance shareholder value, aiming to redefine treatment approaches in its specialized therapeutic areas.

Want to dig deeper into these stocks?